Sign in
Phase II study of dose-dense sequential doxorubicin and docetaxel for patients with advanced operable and inoperable breast cancer
Journal article   Peer reviewed

Phase II study of dose-dense sequential doxorubicin and docetaxel for patients with advanced operable and inoperable breast cancer

Brenda W Cooper, Tomas Radivoyevitch, Beth A Overmoyer, Robert R Shenk, Huong T Pham, Judith R Samuels, Margaret P Parry and Paula Silverman
Breast cancer research and treatment, Vol.97(3), pp.311-318
2006
PMID: 16344915

Abstract

Biological and medical sciences Gynecology. Andrology. Obstetrics Mammary gland diseases Medical sciences Tumors

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Citation topics
1 Clinical & Life Sciences
1.119 Breast Cancer Scanning
1.119.259 HER2
Web Of Science research areas
Oncology
ESI research areas
Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details